Recently we have had numerous NIH SBIR/STTR proposals rejected because they have failed the foreign risk assessment.
SBIR/STTR Benefits
NIST funds diverse innovations with $1.8M in SBIR grants
The National Institute of Standards and Technology (NIST) has awarded over $1.
Prompting TurboInnovate with CTC
You may recall that the CTC has a license to the Omnisync TurboInnovate platform.
How the OBBBA Repeal of Section 174 Could Supercharge Your Startup
Big news for startups and innovators: The One Big Beautiful Bill Act (OBBBA) has reversed the “Innovation Tax” under Section 174.
Access Market Analysis from CTC
We, at the CTC, are excited to announce a new free service we are offering to our clients! We are now able to provide initial Market Research and Competitive Landscape Reports for our client’s technologies and companies.
NSF to vet all grants for banned content
The NSF has recently announced a freeze on funding as the agency is beginning a search through all currently awarded grants to find those that may have been banned by recent executive orders.
Notice of NIH indirect rate decrease to 15%
Historically the NIH has allowed a 40% indirect rate on SBIR and STTR grants without requiring backing evidence.
Navigating Section 174: A Potential Solution for SBIR/STTR Funded Companies
Before diving in, let me clarify: I am not an accountant, nor am I providing tax advice.
NCI STEP – SBIR/STTR Training and Entrepreneurship Program
The National Cancer Institute has created a new Phase 0 program for interested US-based businesses to use.
NIH Grants vs. NIH Contracts (SBIR/STTR)
The NIH is unique amongst SBIR/STTR granting agencies in that it offers both grants and contracts.